Atractylenolide III, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway

Food and Chemical Toxicology

Volumn 49, Issue 2, 2011, Pages 514-519

  Kang, Tae Hee ^a   Bang, Ji Young ^b   Kim, Min Ho ^c   Kang, In Cheol ^b   Kim, Hyung Min ^a   Jeong, Hyun Ja ^b  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Apoptosis inducing factor; Atractylenolide III; Caspase; Cytochrome c; Lung carcinoma cells

Indexed keywords

APOPTOSIS INDUCING FACTOR; ATRACTYLENOLIDE; CASPASE 3; CASPASE 9; CYTOCHROME C; LACTATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; SESQUITERPENOID; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; ATRACTYLODES; CARCINOMA CELL; CELL CYCLE ARREST; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MITOCHONDRION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RHIZOME; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 9; CELL CYCLE; CELL LINE, TUMOR; HUMANS; LACTONES; LUNG NEOPLASMS; MITOCHONDRIA; SESQUITERPENES;

ATRACTYLODES;

EID: 78951484329     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.11.038     Document Type: Article

References (32)

1. Aggarwal B.B., Ichikawa H., Garodia P., Weerasinghe P., Sethi G., Bhatt I.D., Pandey M.K., Shishodia S., Nair M.G. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin. Ther. Targets 2006, 10:87-118.
2. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
3. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
4. Besaratina A., Pfiefer G. Second-hand smoke and human lung cancer. Lancet Oncol. 2008, 9:666-675.
5. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 2003, 39:615-647.
6. Bussolino F., Mantovani A., Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 1997, 22:251-256.
7. Calviello G., Di Nicuolo F., Piccioni E., Marcocci M.E., Serini S., Maggiano N., Jones K.H., Cornwell D.G., Palozza P. Gamma-tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis 2003, 24:427-433.
8. Daugas E., Susin S.A., Zamzami N., Ferri K., Irinopoulos T., Larochette N., Prévost M.C., Leber B., Andrews D., Penninger J., Kroemer G. Mitochondrio-nuclear redistribution of AIF in apoptosis and necrosis. FASEB J. 2000, 14:729-739.
9. Dempsey P.W., Doyle S.E., He J.Q., Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 2003, 14:193-209.
10. Dong H., He L., Huang M., Dong Y. Anti-inflammatory components isolated from Atractylodes macrocephala Koidz. Nat. Prod. Res. 2008, 22:1418-1427.
11. Dove A. Making a living out of the art of dying. Nat. Biotechnol. 2001, 19:615-619.
12. Engels I.H., Stepczynska A., Stroh C., Lauber K., Berg C., Schwenzer R., Wajant H., Janicke R.U., Porter A.G., Belka C., Gregor M., Schulze-Osthoff K., Wesselborg S. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000, 19:4563-4573.
13. Fan T.P., Jaggar R., Bicknell R. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci. 1995, 16:57-66.
14. Fischer U., Janicke R.W., Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003, 10:76-100.
15. Gordon M.S., Mendelson D.S., Kato G. Tumor angiogenesis and novel antiangiogenic strategies. Int. J. Cancer 2010, 126:1777-1787.
16. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
17. Hong S.J., Dawson T.M., Dawson V.L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 2004, 25:259-264.
18. Hu C.B., Chen C.P., Yeh T.K., Song J.S., Chang C.Y., Chuu J.J., Tung F.F., Ho P.Y., Chen T.W., Lin C.H., Wang M.H., Chang K.Y., Huang C.L., Lin H.L., Li W.T., Hwang D.R., Chern J.H., Hwang L.L., Chang J.Y., Chao Y.S., Chen C.T. BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities. Cancer Sci. 2010, 10.1111/j.1349-7006.2010.01744.x.
19. Huang M., Stolina M., Sharma S. Nonsmall cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 1998, 58:1208-1216.
20. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267:2000-2003.
21. Kwon K.B., Kim E.K., Shin B.C., Seo E.A., Park J.W., Kim J.S., Park B.H., Ryu D.G. Induction of apoptosis by takrisodokyeum through generation of hydrogen peroxide and activation of caspase-3 in HL-60 cells. Life Sci. 2003, 73:1895-1906.
22. Li C.Q., He L.C., Jin J.Q. Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother. Res. 2007, 21:347-353.
23. Liu X., Yue P., Zhou Z., Khuri F.R., Sun S.Y. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J. Natl. Cancer Inst. 2004, 96:1769-1780.
24. Magesh V., Lee J.C., Ahn K.S., Lee H.J., Lee H.J., Lee E.O., Shim B.S., Jung H.J., Kim J.S., Kim D.K., Choi S.H., Ahn K.S., Kim S.H. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Phytother. Res. 2009, 23:1385-1391.
25. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 1998, 95:14681-14686.
26. Regula K.M., Ens K., Kirshenbaum L.A. Mitochondria-assisted cell suicide: a license to kill. J. Mol Cell. Cardiol. 2003, 35:559-567.
27. Reynolds A.R. Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response 2010, 8:253-284.
28. Su J.H., Nichol K.E., Sitch T., Sheu P., Chubb C., Miller B.L., Tomaselli K.J., Kim R.C., Cotman C.W. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp. Neurol. 2000, 163:9-19.
29. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.
30. Thrompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
31. Trimmer E.E., Essigmann J.M. Cisplatin. Essays Biochem. 1999, 34:191-211.
32. Woodle E.S., Kulkarni S. Programmed cell death. Transplantation 1998, 66:681-691.